Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

ClinicoEconomics and Outcomes Research


Archive: Volume 9, 2017

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK

Wilson MR, Azzabi Zouraq I, Chevrou-Severac H, Selby R, Kerrigan MC

ClinicoEconomics and Outcomes Research 2017, 9:641-652

Published Date: 16 October 2017

Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

Sheer R, Null KD, Szymanski KA, Sudharshan L, Banovic J, Pasquale MK

ClinicoEconomics and Outcomes Research 2017, 9:629-639

Published Date: 10 October 2017

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark

Poulsen PB, Johnsen SP, Hansen ML, Brandes A, Husted S, Harboe L, Dybro L

ClinicoEconomics and Outcomes Research 2017, 9:617-627

Published Date: 10 October 2017

Epidemiology, patient profile, and health care resource use for hepatitis C in Italy

Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L

ClinicoEconomics and Outcomes Research 2017, 9:609-616

Published Date: 10 October 2017

Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor

Blackwell SC, Sullivan EM, Petrilla AA, Shen X, Troeger KA, Byrne JD

ClinicoEconomics and Outcomes Research 2017, 9:585-594

Published Date: 3 October 2017

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG

ClinicoEconomics and Outcomes Research 2017, 9:573-584

Published Date: 29 September 2017

Technology that achieves the Triple Aim: an economic analysis of the BrainPathTM approach  in neurosurgery

Norton SP, Dickerson EM, Kulwin CG, Shah MV

ClinicoEconomics and Outcomes Research 2017, 9:519-523

Published Date: 26 August 2017

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France

Taipale K, Winfree KB, Boye M, Basson M, Sleilaty G, Eaton J, Evans R, Chouaid C

ClinicoEconomics and Outcomes Research 2017, 9:505-518

Published Date: 16 August 2017

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TGK, Phan AT

ClinicoEconomics and Outcomes Research 2017, 9:495-503

Published Date: 16 August 2017

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US

Mearns ES, Liang M, Limone BL, Gilligan AM, Miller JD, Schaum KD, Waycaster CR

ClinicoEconomics and Outcomes Research 2017, 9:485-494

Published Date: 16 August 2017

The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis

Kiatos E, Armstrong JJ, Hutnik CML, Tsioros SM, Malvankar-Mehta MS, Hodge WG

ClinicoEconomics and Outcomes Research 2017, 9:459-474

Published Date: 9 August 2017

Cost analysis of adverse events associated with non-small cell lung cancer management in France

Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E

ClinicoEconomics and Outcomes Research 2017, 9:443-449

Published Date: 27 July 2017

Cost of illness of urothelial bladder cancer in Italy

Gerace C, Montorsi F, Tambaro R, Cartenì G, De Luca S, Tucci M, Martorana G, Basso U, Cardosi L, Teruzzi C

ClinicoEconomics and Outcomes Research 2017, 9:433-442

Published Date: 24 July 2017

A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients

Lucidi C, Di Gregorio V, Ceccarelli G, Venditti M, Riggio O, Merli M

ClinicoEconomics and Outcomes Research 2017, 9:385-390

Published Date: 29 June 2017

Burden of air leak complications in thoracic surgery estimated using a national hospital billing database

Yoo A, Ghosh SK, Danker W, Kassis E, Kalsekar I

ClinicoEconomics and Outcomes Research 2017, 9:373-383

Published Date: 29 June 2017

The economic and humanistic costs of chronic lower back pain in Japan

Montgomery W, Sato M, Nagasaka Y, Vietri J

ClinicoEconomics and Outcomes Research 2017, 9:361-371

Published Date: 23 June 2017

Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications

Foglia E, Ferrario L, Garagiola E, Signoriello G, Pellino G, Croce D, Canonico S

ClinicoEconomics and Outcomes Research 2017, 9:343-351

Published Date: 12 June 2017

Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

Adkins EM, Nicholson L, Floyd D, Ratcliffe M, Chevrou-Severac H

ClinicoEconomics and Outcomes Research 2017, 9:327-342

Published Date: 10 June 2017

In-center hemodialysis absenteeism: prevalence and association with outcomes

Gray KS, Cohen DE, Brunelli SM

ClinicoEconomics and Outcomes Research 2017, 9:307-315

Published Date: 24 May 2017

Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database

Akiyama S, Tanaka E, Cristeau O, Onishi Y, Osuga Y

ClinicoEconomics and Outcomes Research 2017, 9:295-306

Published Date: 22 May 2017

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis

Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A

ClinicoEconomics and Outcomes Research 2017, 9:281-293

Published Date: 22 May 2017

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

Knight T, Bond TC, Popelar B, Wang L, Niewoehner JW, Anastassopoulos K, Philbin M

ClinicoEconomics and Outcomes Research 2017, 9:271-279

Published Date: 16 May 2017

A retrospective analysis of delays in the diagnosis of lung cancer and associated costs

Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC

ClinicoEconomics and Outcomes Research 2017, 9:261-269

Published Date: 12 May 2017

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy

Degli Esposti L, Veronesi C, Perrone V, Buda S, Santoro A

ClinicoEconomics and Outcomes Research 2017, 9:233-239

Published Date: 27 April 2017

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom

Muthukumar M, Desai K, Abogunrin S, Harrower T, Gabriel S, Dinet J

ClinicoEconomics and Outcomes Research 2017, 9:211-229

Published Date: 15 April 2017

Economic benefit of back titration in the treatment of hypertension in Jos, Nigeria

Okeahialam BN, Adeniyi MA

ClinicoEconomics and Outcomes Research 2017, 9:207-210

Published Date: 10 April 2017

Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant

Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G

ClinicoEconomics and Outcomes Research 2017, 9:201-206

Published Date: 3 April 2017

Survey on attitudes of Italian pediatricians toward cough

Zanasi A, Morcaldi L, Cazzato S, Mazzolini M, Lecchi M, Morselli-Labate AM, Mastroroberto M, Dal Negro RW

ClinicoEconomics and Outcomes Research 2017, 9:189-199

Published Date: 16 March 2017

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J

ClinicoEconomics and Outcomes Research 2017, 9:163-172

Published Date: 27 February 2017

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

Brodszky V, Bíró A, Szekanecz Z, Soós B, Baji P, Rencz F, Tóthfalusi L, Gulácsi L, Péntek M

ClinicoEconomics and Outcomes Research 2017, 9:139-147

Published Date: 15 February 2017

Cost analysis of facial injury treatment in two university hospitals in Malaysia: a prospective study

Saperi BS, Ramli R, Ahmed Z, Muhd Nur A, Ibrahim MI, Rashdi MF, Nordin R, Rahman NA, Yusoff A, Nazimi AJ, Abdul Rahman R, Abdul Razak N, Mohamed N

ClinicoEconomics and Outcomes Research 2017, 9:107-113

Published Date: 7 February 2017

The cost-effectiveness of a NSCLC patient assistance program for pemetrexed maintenance therapy in People's Republic of China

Shi Q, Hu S, Furnback WE, Guzauskas GF, Shen J, Wang BCM

ClinicoEconomics and Outcomes Research 2017, 9:99-106

Published Date: 3 February 2017

Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany

Watson C, Prosser C, Braun S, Landsman-Blumberg PB, Gleissner E, Naoshy S

ClinicoEconomics and Outcomes Research 2017, 9:85-97

Published Date: 1 February 2017

Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany

Green W, Kleine-Tebbe J, Klimek L, Hahn-Pedersen J, Nørgaard Andreasen J, Taylor M

ClinicoEconomics and Outcomes Research 2017, 9:77-84

Published Date: 16 February 2017

Relative cost-effectiveness of using a liquid human milk fortifier in preterm infants in the US

Guest JF, Moya F, Sisk PM, Hudak ML, Kuehn D

ClinicoEconomics and Outcomes Research 2017, 9:49-57

Published Date: 4 January 2017

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C

ClinicoEconomics and Outcomes Research 2017, 9:39-47

Published Date: 30 December 2016

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D

ClinicoEconomics and Outcomes Research 2017, 9:31-38

Published Date: 30 December 2016

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy

Degli Esposti L, Favalli EG, Sangiorgi D, Di Turi R, Farina G, Gambera M, Ravasio R

ClinicoEconomics and Outcomes Research 2017, 9:9-17

Published Date: 21 December 2016

Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital

Pham LD, Phung NHT, Le NTD, Vo TQ

ClinicoEconomics and Outcomes Research 2017, 9:1-8

Published Date: 16 December 2016